Literature DB >> 31751881

Novel BDNF-regulatory microRNAs in neurodegenerative disorders pathogenesis: An in silico study.

Fatemeh Khani-Habibabadi1, Shahrzad Askari1, Javad Zahiri2, Mohammad Javan3, Mehrdad Behmanesh4.   

Abstract

Brain-derived neurotrophic factor (BDNF) is a neurotrophic factor with various roles in the central nervous system neurogenesis, neuroprotection, and axonal guide. By attaching to Tropomyosin receptor kinase B (TrkB) receptor, this protein triggers downstream signaling pathways which lead to cellular growth, proliferation, survival, and neuroplasticity. Deregulation at mRNA level is involved in various central nervous system disorders including, Huntington, Alzheimer's, Multiple Sclerosis, and Amyotrophic Lateral Sclerosis diseases. Considering the importance of BDNF functions, deciphering the regulatory mechanisms controlling BDNF expression level could pave the way to develop more accurate and efficient treatments for neurological diseases. Among different regulatory systems, microRNAs (miRNAs) play prominent roles by targeting genes 3' untranslated regions. In this study, 127 validated and bioinformatic-predicted miRNAs with potentially regulatory roles in BDNF expression were analyzed. Various aspects of miRNAsö possible functions were assessed by bioinformatic online tools to find their potential regulatory functions in signaling pathways, neurological disorders, expression of transcription factors and miRNAs sponge. Analyzed data led to introduce 5 newly reported miRNAs that could regulate BDNF expression level. Finally, high throughput sequencing data from different brain regions and neurological disorders were analyzed to measure correlation of candidate miRNAs with BDNF level in experimental studies. In this study, a list of novel miRNAs with possible regulatory roles in BDNF expression level involving in different neurological disorders was introduced.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brain-derived neurotrophic factor; High-throughput data; In silico study; Neurodegeneration; microRNAs

Year:  2019        PMID: 31751881     DOI: 10.1016/j.compbiolchem.2019.107153

Source DB:  PubMed          Journal:  Comput Biol Chem        ISSN: 1476-9271            Impact factor:   2.877


  5 in total

Review 1.  Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders.

Authors:  Anna Morozova; Yana Zorkina; Olga Abramova; Olga Pavlova; Konstantin Pavlov; Kristina Soloveva; Maria Volkova; Polina Alekseeva; Alisa Andryshchenko; Georgiy Kostyuk; Olga Gurina; Vladimir Chekhonin
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

2.  miR-182-5p combined with brain-derived neurotrophic factor assists the diagnosis of chronic heart failure and predicts a poor prognosis.

Authors:  Fang Fang; Xiaonan Zhang; Bin Li; Shouyi Gan
Journal:  J Cardiothorac Surg       Date:  2022-04-30       Impact factor: 1.522

3.  MicroRNA editing patterns in Huntington's disease.

Authors:  Shiyong Guo; Jun Yang; Bingbing Jiang; Nan Zhou; Hao Ding; Guangchen Zhou; Shuai Wu; Angbaji Suo; Xingwang Wu; Wenping Xie; Wanran Li; Yulong Liu; Wei Deng; Yun Zheng
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

Review 4.  Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer.

Authors:  Luca Colucci-D'Amato; Luisa Speranza; Floriana Volpicelli
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923

Review 5.  Huntingtin and Its Role in Mechanisms of RNA-Mediated Toxicity.

Authors:  Annika Heinz; Deepti Kailash Nabariya; Sybille Krauss
Journal:  Toxins (Basel)       Date:  2021-07-14       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.